Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nutt

Showing results (781-790 of 790) with videos related to

Pageof 79
Sort By:
You have reached the last page of results.This site can display upto 790 results.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Neural correlates of the LSD experience revealed by multimodal neuroimagingRobin L Carhart-Harris, Suresh Muthukumaraswamy, Leor Roseman, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 8, 2023
Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment DurationJulien Guiraud, Giovanni Addolorato, Henri-Jean Aubin, et al.
Nature Medicine|April 6, 2026
An international mega-analysis of psychedelic drug effects on brain circuit functionManesh Girn, Manoj K Doss, Leor Roseman, et al.
Journal of Psychopharmacology (Oxford, England)|July 7, 2022
Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trialJulien Guiraud, Giovanni Addolorato, Mariangela Antonelli, et al.
Journal of Psychopharmacology (Oxford, England)|August 7, 2015
The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study descriptionLouise M Paterson, Remy S A Flechais, Anna Murphy, et al.
Journal of Neurochemistry|May 19, 2026
Towards Mechanism-Informed Treatments for Mental HealthIker Bengoetxea de Tena, Farhanah Nabilah Sallie, Arvie Rodriguez Abiero, et al.
Molecular Psychiatry|June 15, 2023
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depressionSameer Jauhar, Danilo Arnone, David S Baldwin, et al.
BMJ (Clinical Research Ed.)|July 3, 2020
Open letter from UK based academic scientists to the secretaries of state for digital, culture, media and sport and for health and social care regarding the need for independent funding for the prevention and treatment of gambling harmsHeather Wardle, James Banks, Paul Bebbington, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 2, 2013
Stratified medicine for mental disordersGunter Schumann, Elisabeth B Binder, Arne Holte, et al.
CNS Spectrums|July 15, 2022
The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depressionVincent Van den Eynde, Wegdan R Abdelmoemin, Magid M Abraham, et al.
Pageof 79

Showing results (781-790 of 790) with videos related to

Sort By:
Pageof 79
You have reached the last page of results.This site can display upto 790 results.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Neural correlates of the LSD experience revealed by multimodal neuroimagingRobin L Carhart-Harris, Suresh Muthukumaraswamy, Leor Roseman, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 8, 2023
Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment DurationJulien Guiraud, Giovanni Addolorato, Henri-Jean Aubin, et al.
Nature Medicine|April 6, 2026
An international mega-analysis of psychedelic drug effects on brain circuit functionManesh Girn, Manoj K Doss, Leor Roseman, et al.
Journal of Psychopharmacology (Oxford, England)|July 7, 2022
Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trialJulien Guiraud, Giovanni Addolorato, Mariangela Antonelli, et al.
Journal of Psychopharmacology (Oxford, England)|August 7, 2015
The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study descriptionLouise M Paterson, Remy S A Flechais, Anna Murphy, et al.
Journal of Neurochemistry|May 19, 2026
Towards Mechanism-Informed Treatments for Mental HealthIker Bengoetxea de Tena, Farhanah Nabilah Sallie, Arvie Rodriguez Abiero, et al.
Molecular Psychiatry|June 15, 2023
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depressionSameer Jauhar, Danilo Arnone, David S Baldwin, et al.
BMJ (Clinical Research Ed.)|July 3, 2020
Open letter from UK based academic scientists to the secretaries of state for digital, culture, media and sport and for health and social care regarding the need for independent funding for the prevention and treatment of gambling harmsHeather Wardle, James Banks, Paul Bebbington, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 2, 2013
Stratified medicine for mental disordersGunter Schumann, Elisabeth B Binder, Arne Holte, et al.
CNS Spectrums|July 15, 2022
The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depressionVincent Van den Eynde, Wegdan R Abdelmoemin, Magid M Abraham, et al.
Pageof 79